ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION

Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations and agreements on the taxation of global income and the potential impacts on the tax base of the U.S. and its Territories. Issues related to IRC sections 11, 951A, 250, 163(j), 168, 55, 56A, 59, 174 and 41. (H.R. 2673, H.R. 7024).